SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...

Its Labs of the Future initiative has resulted ... to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease ...

Myriad Genetics , Inc. (NASDAQ:MYGN) stock has reached a new 52-week low, touching down at $12.16, as the company faces a challenging market environment. According to InvestingPro data, technical ...

SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its Quality, Innovation, and Corporate ...

Myriad continues to position itself as a leader in genetic testing and precision medicine ... assays and its Labs of the Future initiative, which aims to enhance efficiency and reduce operating ...

Myriad Medical Supply today announced that the company has upgraded its portfolio of disposable medical products and hired David Nichols, a veteran leader in the healthcare industry, to serve ...

At-home test kits offer a convenient way to monitor health conditions privately, using advanced technologies for accurate and ...

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.

Results: Myriad Genetic's BRCA1/2 gene patents sparked ... the threat of patent infringement action against government testing laboratories and potential impacts on public health care.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced updates to its agreement with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing ...